« Previous
Next »
Journal of Vascular Surgery
Volume 44, Issue 4
, Pages 732-739
, October 2006
Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans
References
- . Thromboangiitis obliterans (Buerger’s disease) . N Engl J Med . 2000;343:864–869
- . Plasma catecholamines in Buerger’s disease: effects of cigarette smoking and surgical sympathectomy . Eur J Vasc Endovasc Surg . 2002;24:338–343
- . Regenerative medicine for cardiovascular disorders (New milestones: adult stem cells) . Artif Organs . 2006;30:213–232
- Isolation of putative progenitor endothelial cells for angiogenesis . Science . 1997;275:964–967
- . Endothelial progenitor cells: mobilization, differentiation, and homing . Arterioscler Thromb Vasc Biol . 2003;23:1185–1189
- . Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration . Nat Med . 2003;9:702–712
- . Endothelial progenitor cells for postnatal vasculogenesis . Am J Physiol Cell Physiol . 2004;287:C572–C579
- . Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization . J Clin Invest . 1999;103:1231–1236
- Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial . Lancet . 2002;360:427–435
- Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia . Circulation . 2004;109:1215–1218
- Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells . Circ J . 2004;68:1189–1193
- . Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes . Diabetes Care . 2005;28:2155–2160
- Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities . Thromb Haemost . 2004;91:606–609
- Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia . Circ J . 2005;69:1260–1265
- Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation . Ther Apher Dial . 2005;9:59–63
- Recommended standards for reports dealing with lower extremity ischemia: revised version . J Vasc Surg . 1997;26:517–538
- . Diagnostic criteria of Buerger’s disease . Int J Cardiol . 1998;66:S243–S245
- . Comparison of two progressive treadmill tests in patients with peripheral arterial disease . Vasc Med . 2001;6:215–221
- . Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia . J Vasc Surg . 2001;33:679–687
-
.
Depletion of donors erythrocytes using cell separator in major ABO mismatched allogeneic bone marrow transplantation
.
Blood
. 2000;96:5152
-
Implantation of autologous bone marrow mononuclear cells for Buerger’s disease with retractable limb ischaemia
.
Bone Marrow Transplant
. 2005;35:S76
- Thoracic Surgery Directors Association Award (Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures) . Ann Thorac Surg . 1999;68:301–307
- . Origin of endothelial progenitors in human postnatal bone marrow . J Clin Invest . 2002;109:337–346
- Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization . Proc Natl Acad Sci U S A . 2000;97:3422–3427
- . Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences . Circ Res . 2004;95:354–363
- . Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards . Cardiovasc Res . 2001;49:532–542
- Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication . Circulation . 2003;108:1933–1938
- Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease . Cell Transplant . 2002;11:747–752
-
Therapeutic angiogenesis by autologous transplantation of bone-marrow mononuclear cells for Buerger’s patients with retractable limb ischaemia
(Preliminary results)
.
Turkish J Haematology
. 2004;21:13–21
- . The changing clinical spectrum of thromboangiitis obliterans (Buerger’s disease) . Circulation . 1990;82:IV3–IV8
- . Long-term survival and amputation risk in thrombangiitis abliterans (Buerger’s disease) . J Am Coll Cardiol . 2004;44:2410–2411
- . Clinical and social consequences of Buerger disease . J Vasc Surg . 2004;39:176–180
- . Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors . Arterioscler Thromb Vasc Biol . 2001;21:1712–1719
- Use of synchrotron radiation microangiography to assess development of small collateral arteries in a rat model of hindlimb ischemia . Circulation . 1997;95:805–808
This work was supported by the Biotechnology Institute Research Fund and Ankara University School of Medicine Research Council, Turkey. Dr Arat has been supported by the Turkish Academy of Sciences, in the framework of the Young Scientist Award Program (EA-TUBA-GEBIP/2004-1-1).Competition of interest: none.
PII: S0741-5214(06)01142-6
doi: 10.1016/j.jvs.2006.06.023
© 2006 The Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Vascular Surgery
Volume 44, Issue 4
, Pages 732-739
, October 2006
